Synthetic Nanodisc Human Cannabinoid Receptor I Protein
Descrizione
Synthetic nanodiscs offer a stable and biologically relevant environment that closely mimics cell membranes and enables full-length transmembrane human Cannabinoid Receptor I protein to be purified and analysed in vitro.
Applicazioni
ELISA, SDS-PAGE
Sistema di espressione
HEK293 cells
Tipo di proteina
Synthetic
Specie proteiche
Human
Lunghezza
Full length protein.
Peso molecolare
Full length human Cannabinoid Receptor I protein has a MW of 52.7 kDa.
Coniugare
Unconjugated
Forma del prodotto
Lyophilized
Concentrazione
Reconstitution dependent.
Formulazione
Lyophilized from nanodisc solubilization buffer (20mM Tris-HCl, 150mM NaCl, pH 8.0). Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Conservazione
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Figure 1: Synthetic Nanodisc Human Cannabinoid Receptor I Protein (A318475)
ELISA plates were pre-coated with Synthetic Nanodisc Human Cannabinoid Receptor I Protein (A318475) (0.2 µg/well). Serial diluted Anti-Cannabinoid Receptor I Antibody [DM144] - Azide free (A318564) solutions were added, washed, and incubated with secondary antibody before ELISA reading. From this data, the EC50 for Anti-CB1 Monoclonal Antibody binding with CB1-Nanodisc is 41.62 µg/ml.
Figure 3: Synthetic Nanodisc Human Cannabinoid Receptor I Protein (A318475)
Diagram showing how synthetic nanodiscs containing full-length multi-pass transmembrane proteins in a phospholipid bilayer are generated from native cell membranes.
Prodotti alternativi a Sintetico Nanodisc Umano Cannabinoid Receptor I proteinaa (A318475)
